19 May 2022 in Cell Death & Disease
Circular RNA (circRNA) is a type of non-coding RNA that is widely expressed in mammals. It is highly conserved and abundantly expressed in the brain. Here, we report the regulatory role of circRNA derived from the pantothenate kinase 1 (Pank1) gene (circ-Pank1) in Parkinson’s disease (PD). Circ-Pank1 is highly expressed in the substantia nigra (SN) of PD model mice treated with rotenone and in the MN9D cell model of dopaminergic neurons. The circ-Pank1 knockdown ameliorated dopaminergic neuron damage and locomotor dysfunction after the treatment with rotenone. We found that circ-Pank1 could adsorb miR-7a-5p and upregulate the expression of α-synuclein (α-syn), which is a molecular hallmark closely related to PD. The inhibition of miR-7a-5p reversed the circ-Pank1 knockdown-induced amelioration of dopaminergic neuron injury. In conclusion, circ-Pank1 is overexpressed in PD and enhances the locomotor dysfunction via the miR-7a-5p/α-syn signaling axis. We revealed the functional role of circRNAs in the progression of PD and provided a potential target for noncoding RNAs in delaying the progression of PD.
10 November 2025 in Cell Death Discovery
Parkinson’s disease (PD) is clinically characterized by motor dysfunction, and its pathology primarily involves the progressive loss of dopaminergic neurons. Despite extensive research, the precise etiological mechanisms remain elusive. Recent findings have revealed a significant role of astrocytes in PD onset and progression. However, fully elucidating their function has been challenging because of the heterogeneity of cells and the complexity of the disease progression. Here, we successfully used single-nuclear RNA sequencing to characterize diverse genes expressed by astrocytes and analyzed changes in biological processes in a PD mouse model. Pseudotime analysis (Monocle2) indicated that as PD progressed the status of astrocytes transitioned from immune activation states to neurotoxic subtypes, which correlates with marked upregulation of inflammation-related genes, including Nlrp3 and IL-1β. Furthermore, CellChat analysis demonstrated that BMP signaling exhibited significant specificity in PD, with Bmp6 as the primary ligand and astrocytes as crucial mediators and responders. Thus, we demonstrated that BMP signaling activation in astrocytes exacerbates dopamine neuronal death. Rather, inhibiting BMP signaling in astrocytes significantly improved motor dysfunction and reduced the loss of dopamine neurons in a PD mouse model. Mechanistically, we found that activation of the BMP signaling pathway promoted the release of Nlrp3, IL-1β, and TNF-α, suggesting that increased neuroinflammation aggravated dopaminergic neuronal death. Together, these findings highlight the crucial role of astrocytes in the pathogenesis of PD and reveal a novel cellular mechanism that offers potential therapeutic targets for PD intervention.
27 September 2026 in Advanced Science
Nrf2 dysfunction is implicated in learning and memory deficits, but the involvement of non‐coding RNAs in Nrf2‐dependent cognitive regulation remains largely unexplored. Here, by analyzing the expression profiles of lncRNAs and mRNAs in the hippocampus of wild‐type (WT) and Nrf2 knockout (Nrf2 −/− ) mice, we identified a decreased expression of lncRNA Gm26550 in Nrf2 −/− mice. Overexpression of Gm26550 enhances hippocampal neuronal synaptic plasticity and rescues learning and memory deficits in Nrf2 −/− mice. Mechanistically, Nrf2 directly binds the promoter of Gm26550 to drive its transcriptional activation and upregulate its expression. Gm26550 elevates IGF1 abundance via two regulatory pathways to maintain cognitive function: first, it functionally counteracts miR‐26a‐5p‐mediated repression of IGF1; second, it interacts with the KH3/KH4 domain of KHSRP to block KHSRP‐triggered degradation of IGF1 mRNA. Collectively, our results reveal that Gm26550 maintains IGF1 expression and transcript stability through miR‐dependent antagonism and RBP sequestration, thereby governing learning and memory downstream of Nrf2. This work expands the understanding of the downstream molecular network controlled by Nrf2.